InvestSMART

Botanix Pharmaceuticals Ltd (ASX: BOT) - Announcements

- Current share price for BOT : $0.013

ASX company news and announcements for Botanix Pharmaceuticals Ltd (BOT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Botanix Pharmaceuticals Ltd (BOT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Botanix Pharmaceuticals Ltd (BOT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Botanix Pharmaceuticals Ltd (BOT)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$36 Appendix 4C - quarterly 31 Jul 2017 12:39AM $0.046 $0.013 fallen by 71.74%
$36 Company Presentation 11 Jul 2017 8:24AM $0.046 $0.013 fallen by 71.74%
$36 Botanix Completes Successful Phase 1 BTX 1503 Clinical Study 3 Jul 2017 9:53AM $0.043 $0.013 fallen by 69.77%
$36 Trading Halt 30 Jun 2017 9:35AM $0.043 $0.013 fallen by 69.77%
$36 12 Month Operational Review Highlights Significant Progress 27 Jun 2017 9:28AM $0.042 $0.013 fallen by 69.05%
$36 Successful Pilot Study for BTX 1701 Facial Cleanser 8 Jun 2017 9:02AM $0.041 $0.013 fallen by 68.29%
$36 Completion of Tranche 2 of Capital Raising Placement 19 May 2017 3:28PM $0.050 $0.013 fallen by 74%
$36 Appendix 3B 19 May 2017 3:26PM $0.050 $0.013 fallen by 74%
$36 Results of Meeting 15 May 2017 2:15PM $0.050 $0.013 fallen by 74%
$36 Appendix 3B 9 May 2017 8:42AM $0.051 $0.013 fallen by 74.51%
$36 Botanix Commences First Clinical Study for BTX 1503 8 May 2017 8:56AM $0.051 $0.013 fallen by 74.51%
$36 Botanix Presents at Investor Seminar 4 May 2017 8:29AM $0.050 $0.013 fallen by 74%
$36 Appendix 4C - quarterly 28 Apr 2017 8:16AM $0.051 $0.013 fallen by 74.51%
$36 Notice of General Meeting/Proxy Form 13 Apr 2017 4:32PM $0.055 $0.013 fallen by 76.36%
$36 Change in substantial holding 13 Apr 2017 4:28PM $0.055 $0.013 fallen by 76.36%
$36 Change in substantial holding 13 Apr 2017 4:09PM $0.056 $0.013 fallen by 76.79%
$36 Appendix 3B 12 Apr 2017 3:28PM $0.057 $0.013 fallen by 77.19%
$36 Completion of the Tranche 1 Placement 12 Apr 2017 3:24PM $0.057 $0.013 fallen by 77.19%
$36 Reinstatement to official quotation 5 Apr 2017 9:31AM $0.068 $0.013 fallen by 80.88%
$36 Capital Raising Presentation 5 Apr 2017 9:31AM $0.068 $0.013 fallen by 80.88%
$36 Botanix Raises A$7.4 Million in Oversubscribed Placement 5 Apr 2017 9:31AM $0.068 $0.013 fallen by 80.88%
$36 Suspension from Official Quotation 4 Apr 2017 8:59AM $0.068 $0.013 fallen by 80.88%
$36 Trading Halt 31 Mar 2017 9:18AM $0.068 $0.013 fallen by 80.88%
$36 Botanix Receives Approval for Synthetic Cannabidiol Trial 30 Mar 2017 9:05AM $0.058 $0.013 fallen by 77.59%
$36 Export and Import Approvals for Clinical Studies Received 24 Mar 2017 8:26AM $0.057 $0.013 fallen by 77.19%

651 - 675 of 720 results

Page 27 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.